Skip to main content
Download PDF
Download ePub

Higher pulse wave velocity in young adult offspring of mothers with type 1 diabetes: a case–control study

Cardiovascular Diabetology volume 21, Article number: 178 (2022) Cite this article

Abstract

Background

Offspring of mothers with type 1 diabetes have an increased risk for acquiring early onset cardiovascular disease (CVD). Arterial stiffness, measured as pulse wave velocity (PWV), is a non-invasive biomarker for CVD risk assessment. Our aim is to determine whether PWV is increased in young adult offspring of mothers with type 1 diabetes.

Methods

This is a case–control study carried out in the hospital district of Helsinki and Uusimaa, Finland. 75 offspring of mothers with type 1 diabetes (cases) and 84 offspring of mothers without diabetes (controls), aged 18–23 years, were enrolled in this study. All participants attended clinical assessments, including questionnaires and laboratory tests. Carotid-femoral PWV (cfPWV), carotid-radial PWV (crPWV), and PWV ratio were measured from each participant using the Complior Analyse mechanotransducer (Alam Medical, France). Student’s t-test and chi-squared test were used to assess differences between the groups. Stata 17.0, StataCorp LP (College Station, TX, USA) statistical package was used for the analysis.

Results

We did not observe any differences in conventional CVD risk factors: systolic blood pressure, LDL, HbA1c, and smoking between cases and controls. We detected higher cfPWV in cases 6.5 (SD ± 1.2) m/s than in controls 6.2 (SD ± 0.7) m/s, p = 0.049, after adjustments for BMI, smoking, mean arterial pressure, height, and pulse rate was made. We did not observe any difference between cases and controls regarding crPWV or PWV ratio. Additionally, we detected no sex differences.

Conclusions

We report a novel finding of signs of increased arterial stiffness already in young adult offspring of mothers with type 1 diabetes compared to matched offspring of mothers without diabetes. Our finding suggests that exposure to an adverse intrauterine environment of type 1 diabetes mothers may affect the vascular health of offspring already in young adulthood. Additional research within this topic is warranted.

Introduction

The global burden of cardiovascular disease (CVD) is well-documented, accounting for over 30% of mortality in the United States alone [1]. To address the harmful effects of CVD, the United Nations included as one of their sustainable development goals to reduce preterm mortality from noncommunicable diseases by one third prior to 2030 [2]. Therefore, to achieve this long-term target, identifying new biomarkers for early cardiovascular risk assessment are needed.

The development of CVD is known to start already in childhood and young adolescence, simultaneously with the accumulation of CVD risk factors [3]. However, accumulating evidence suggests that an increased CVD risk could originate already in prenatal life. More specifically, the developmental origin of health and disease (DOHaD) hypothesis proposes that an abnormal intrauterine milieu may trigger fetal programming, effects that lead to elevated offspring risk of chronic diseases in adulthood [4, 5]. Indeed, there is evidence that maternal risk factors, such as diabetes and obesity, increase the risk for a poorer metabolic profile and early-onset CVD in the offspring [5,6,7].

In recent decades increased arterial stiffening has emerged as a potent biomarker for individual CVD risk evaluation. Stiffening of the large arteries initiates a complex pathophysiological process, resulting in elevated afterload and enhanced pulsatility in the peripheral tissues, which results in subclinical CVD damage [8, 9]. Arterial stiffening occurs naturally with aging [10, 11], however, the presence of traditional CVD risk factors, such as elevated blood pressure (BP), type 2 diabetes, dyslipidemia, and obesity, steepens the increase in vascular stiffness [10, 11]. Hence, arterial stiffness can be considered a distinct measure of biological aging within the vasculature [12].

It is possible to measure arterial stiffness through several non-invasive methods [13], and pulse wave velocity (PWV) has gained popularity. Carotid-femoral PWV (cfPWV) is accepted by the American Heart Association (AHA) as the gold-standard measurement for PWV [14]. Higher cfPWV, or increased arterial stiffness, has been associated with several traditional CVD risk factors [11, 15]. cfPWV has been shown to improve CVD event prediction and adding PWV to standard risk factors has been shown to reclassify individuals at intermediate risk [16]. It has previously been shown that the presence of CVD risk factors in adolescence, such as obesity and type 2 diabetes, accelerates vascular stiffening in comparison to healthy controls. This highlights that CVD risk factors affect vascular aging, thus also individual CVD risk already at a young age [17].

With the DOHaD hypothesis in mind, we wanted to assess whether CVD risk factors and arterial stiffness differed in young adult offspring of mothers with type 1 diabetes compared to matched offspring of mothers without diabetes. Our hypothesis was that PWV could serve as an early non-invasive biomarker for identifying early vascular changes in young adult offspring born to mothers with type 1 diabetes. The aim of this study was to determine whether increased PWV could be observed in young adult offspring of mothers with type 1 diabetes.

Methods

This is a case–control study carried out in the Hospital District of Helsinki and Uusimaa, Finland. During the period between January 1st 1996 and January 31st 2000 all deliveries of type 1 diabetes pregnancies from the city of Helsinki and the province of Uusimaa were managed at the Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland. All case participants, i.e., offspring of mothers with type 1 diabetes (n = 238), were delivered through elective caesarean section from a singleton pregnancy. The control participants (n = 476) consisted of the first or the second offspring of women without diabetes, delivered at different obstetrical departments across the Hospital District of Helsinki and Uusimaa, Finland. Data on birth of study participants were obtained from the Finnish Medical Birth Register (http://www.thl.fi/en/statistics/parturients) held by the Finnish Institute for Health and Welfare, Finland.

In 2019 all case and control participants were invited to a clinical study. The contact information of ten case participants and thirty-four control participants were not available. Eighty-one (36%) of the invited case participants (n = 228) attended, whereas 86 (20%) of the invited control participants (n = 442) attended. Four participants were excluded from the study population, as one control participant did not perform the standard 75 g 2 h-oral glucose tolerance test (OGTT), while three of the case participants were diagnosed with type 1 diabetes. In total, the study population consisted of 163 subjects.

The clinical study, including clinical assessment, laboratory tests, and questionnaires, was performed by trained study nurses.

Height was measured without shoes using a standardized measuring rod against the wall with an accuracy of 0.1 cm (SECA Telescopic measuring rod, SHZ, cm INT). A bioimpedance body composition device (InBody 3.0, Biospace, Seoul, South Korea) was used to measure body weight (kg) and fat mass (kg) of each participant in light indoor clothing without shoes and socks with an accuracy of 0.1 kg. BMI was calculated as body weight divided by height squared (kg/m2). Body fat percentage (%) was calculated as the ratio of fat mass (kg) divided by body weight (kg) multiplied by 100. BP was measured from each participant’s right arm with a standardized BP-monitor (Omron Intellisense M6 AC, Omron Healthcare Co. Ltd., Japan) in a sitting position after 15 min of rest, with a cuff size of 22 × 42 mm. The mean value of three BP measurements were documented, then inserted in the calculations of pulse pressure (PP = systolic BP—diastolic BP) and mean arterial pressure (MAP = diastolic BP + 1/3 × PP). The BP-monitor measured the pulse rate (beats per minute) simultaneously, which was documented.

PWV was measured from each participant after 10 h of fasting, in a silent and normal temperature room. The Complior Analyse device and software (Alam Medical, Vincennes, France) was used to assess PWV. The sensors were attached at the carotid-, radial-, and femoral arteries. The recordings were obtained by trained study nurses from each participant after 10 min of rest in the supine position. The mean value of two recordings was documented. PWV was calculated as the distance traveled (m) by the pulse wave between the two recording sites (carotid-femoral or carotid-radial) and divided by the pulse transit time (s) between the two sites. The PWV distance was measured as a direct line with a tape measure between the recording sites of the carotid artery and the femoral or radial artery. According to the general guidelines, this absolute distance was adjusted by a scaling factor of 0.8 [14]. We evaluated the cfPWV of each study participant which is a proxy measure of stiffness in the large elastic arteries (aorta), and the crPWV, which is a proxy measure of stiffness in the peripheral muscular arteries (brachial). Furthermore, we assessed the arterial stiffness gradient, or PWV ratio, by calculating the ratio of cfPWV to crPWV.

After 10 h of fasting, blood samples for assessment of HbA1c, fasting plasma glucose, LDL, HDL, total cholesterol, triglycerides, and high-sensitive C-reactive protein (hs-CRP) were collected from each participant. A 75 g 2-h oral glucose tolerance test (2 h-OGTT) was performed according to the World Health Organization’s (WHO) criteria with simultaneous assessment for insulin resistance by the homeostatic model assessment (HOMA-IR) [18].

Questionnaires were used to gather self-reported information regarding general health, chronic diseases, and smoking status.

Exercise was assessed using the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) 12-month questionnaire of leisure-time physical activity (LTPA) [19]. Participants were asked to report their physical activity during the previous year (duration, number of occasions, intensity). Metabolic equivalent of task (MET)-values were assigned to each activity according to available data (1 MET = 3.5 ml O2/kg/min) [20]. The volume of LTPA was reported as MET-hours (MET-h) per week, which was calculated as a sum of product of each activities MET value, duration, and frequency.

This study was approved by the Ethics Committee of the Hospital District of Helsinki and Uusimaa (HUS/898/2017, 14 December 2017) and was conducted according to the ethical principles of the Helsinki Declaration. Prior to any clinical procedure written consent was provided by all study participants.

The descriptive statistics are presented as means with standard deviation (SD), and as counts with percentages. Group differences were evaluated using unpaired Student’s t-test, and chi-squared test, as appropriate. Relationships between PWV measurements in cases and controls, further divided by sex, was analyzed using two-way analysis of variance (ANOVA). In the case of violation of the assumptions (e.g., non-normality) for continuous variables, a bootstrap-type method or MonteCarlo p-values (small number of observations) for categorical variables was used. The normality of variables was evaluated graphically and by using the Shapiro–Wilk W-test. The Stata 17.0, StataCorp LP (College Station, TX, USA) statistical package was used for the analysis.

Results

Table 1 shows the characteristics of the study population. The mean age of the cases was 20.5 (SD 1.6) years, whereas the mean age of the controls was 20.6 (SD 1.6) years.

Table 1 Clinical characteristics of study participants divided into offspring of mothers without diabetes (controls) and offspring of mothers with type 1 diabetes (cases)
Full size table

We did not observe any differences between cases and controls in BMI, systolic BP, diastolic BP, or LTPA.

Figure 1 shows the different PWV measurements in cases and controls, further divided by sex. The cfPWV values were higher in adult offspring of mothers with type 1 diabetes [6.5 (SD ± 1.2) m/s] than in adult offspring of mothers without diabetes [6.2 (SD ± 0.7)m/s, p = 0.049], after adjustments for BMI, smoking, height, MAP, and pulse rate. We did not find any differences between the cases and controls for crPWV or for PWV ratio, further adjustments did not change the results. We did not observe any significant differences between the sexes for cfPWV, crPWV, or for PWV ratio.

Fig. 1
figure 1

PWV measurements in offspring of mothers with type 1 diabetes (cases) and offspring of mothers without diabetes (controls), further divided by sex and type of PWV measured; cfPWV (a); crPWV (b); PWV ratio (c). Adjusted for: BMI, smoking, mean arterial pressure, height, and pulse. cfPWV carotid-femoral pulse wave velocity, crPWV carotid-radial pulse wave velocity, PWV ratio cfPWV/crPWV

Full size image

Discussion

We report a novel and interesting finding that offspring of mothers with type 1 diabetes have increased arterial stiffness when compared to offspring of mothers without diabetes already in young adulthood. This observation would suggest that exposure to abnormal intrauterine environment—in this case maternal type 1 diabetes—during fetal development may affect vascular health in offspring already in young adulthood.

Previous studies have shown that adult offspring of mothers with diabetes have an increased risk of acquiring early onset CVD. In a Danish population-based cohort study, Yu et al. reported that during a 40-year follow-up, offspring of mothers with pregestational diabetes had a hazard ratio (HR) of 1.29 to develop early onset CVD [6]. Although the exact mechanism remains unknown, the earliest signs of CVD could originate already in the developing fetus, possibly mediated through epigenetic mechanisms [21]. Murray et al. reported that maternal risk factors during pregnancy could induce DNA methylation in the offspring’s genome at birth, which in turn, was found to be associated with enhanced arterial stiffening after a follow-up of 8–9 years [22]. In addition, offspring of mothers with pregestational diabetes have been observed to have an increased risk for pathological ventricular hypertrophy already at birth [23]. Albeit there might be a relationship between individuals exposed to maternal type 1 diabetes in utero and the risk of CVD, yet surprisingly, we could not find any signs of clinical CVD in young adulthood. One possible explanation might be related to the young age of our study participants. The vascular changes that occur in order to develop CVD most often consist of a several decades-long process, and naturally, the incidence of pathognomical abnormalities of vascular disease are much rarer in young adults [1]. This would require more invasive measures to identify. Also, the role of epigenetics in the transmission of CVD risk heritage may be one of the mechanisms involved, however, as there is still a gap in the understanding of epigenetics, its role in the development of CVD remain incomplete [24].

In 2010 the European Society of Cardiology (ESC) established reference values for cfPWV measurements per age decade and for different BP levels; for instance, in under 30-year-olds with optimal BP-levels (less than 120/80 mmHg), the 90th percentile for cfPWV was under 7.0 m/s [25]. In addition, an expert consensus statement proposed that a cut-off value of 10 m/s for cfPWV to be used in the prediction of CVD events [26]. This could be interpreted to suggest that subclinical organ damage is not present in our study population, although the mean cfPWV value that we observed in offspring of mothers with type 1 diabetes was higher than the mean cfPWV observed in offspring of mothers without diabetes. However, due to the lack of published studies measuring PWV in adults born to mothers with pregestational diabetes, it is difficult to interpret our results in a generalized context. In 2020, Yuan et al. assessed cfPWV in six-year-olds born to mothers with gestational diabetes, however, they observed increased stiffness only in male offspring of mothers with gestational diabetes for cfPWV [27]. When comparing our results to study populations with similar ethnic and age profiles, e.g. Petterson-Pablo et al. assessed vascular status in healthy Swedish young adults (mean age 22 ± 2.0 years) [28]. The mean cfPWV value in both male participants (5.6 ± 0.86 m/s) and female participants (5.2 ± 0.69 m/s) was lower than the value we observed in our study participants [28]. Longitudinal studies have reported that increased arterial stiffness could precede the development of hypertension and diabetes, supposedly being the first change to occur in the development of CVD [29, 30]. Taken together, our results suggest that young adult offspring of mothers with type 1 diabetes have subtle vascular stiffening, which may convert into clinical CVD later in life.

There is mounting evidence to support findings that offspring of mothers with type 1 diabetes have an increased risk for developing obesity, abnormal glucose regulation, and a poorer metabolic profile than offspring born to mothers without diabetes [31, 32]. More worryingly, Lindsay et al. reported that the increased risk for overweight and obesity in offspring of type 1 diabetes mothers can be observed already in childhood [33]. The presence of CVD risk factors in childhood, such as adiposity, hypertension, and dyslipidemia, have a tendency to track into adulthood, consequently affecting CVD risk already at younger ages [34]. Indeed, the Cardiovascular Risk in Young Finns-study reported that the presence of risk factors, such as obesity and type 2 diabetes, severely accelerates vascular stiffening already in childhood, and that only the reduction of CVD risk factors or weight loss predicted the reduction in arterial stiffness in adulthood [35]. Yet, surprisingly, we were unable to find any significant differences in the traditional CVD risk factors between cases and controls in this study. One possible explanation might derive from a healthier lifestyle among offspring of mothers with type 1 diabetes. We believe that the implementation of lifestyle counseling in the Finnish society for all type 1 diabetes patients might have benefitted the habitual patterns within these families. It was recently noticed that offspring of mothers with better cardiovascular health developed later CVD in comparison to offspring of mothers with poorer cardiovascular health [36]. Consequently, a healthy and favorable lifestyle during childhood could have suppressed any clinical differences that might have otherwise occurred between the two study groups.

Further, chronic inflammation is known to accelerate the formation of atherosclerotic lesions within the vasculature and is present early in the development of CVD [37, 38]. As a marker of chronic inflammation, we assessed hs-CRP in our study population, however, this result remained non-significant between the groups.

For a comprehensive arterial stiffness analysis, we included crPWV and PWV ratio assessment in our study participants. The PWV ratio (cfPWV/crPWV) derives from changes that occur with aging, as central arterial stiffness increases, peripheral arterial stiffness remains or decreases [39]. This results in an inversed arterial stiffness gradient, which has shown to provide an alternative method for predicting CVD outcomes [40]. The authors of the Framingham Heart Study addressed this question in a general population setting, concluding that PWV ratio did not improve CVD prediction in comparison to cfPWV, and that cfPWV should be used as the standard measure of arterial stiffness [41]. In the present study, we could not observe any significant differences between the groups for crPWV or for PWV ratio. Additionally, the PWV ratio is under 1 in both cases and controls, suggesting that the arterial stiffness gradient is not inversed. Although our study is limited to a small population size, our results indicate that a normal arterial stiffness gradient, or PWV ratio under 1, might not be a suitable method for assessing early subclinical CVD changes in younger age groups.

It is widely acknowledged that physical activity has beneficial effects in reducing the risk for acquiring non-communicable diseases [42]. Hence, it is unsurprising, that increased physical activity reduces arterial stiffness [43, 44]. We assessed physical activity as the volume of LTPA in our study participants, however, we were unable to find any differences (p-value 0.89) between the cases (24.1 MET-h/week) and controls (24.3 MET-h/week). Wahid et al. conducted a meta-analysis investigating the relationship between physical activity with CVD and diabetes [45]. In comparison to inactive behaviour, the meta-analysis found that medium physical activity (defined as 11.5–29.5 MET-h/week) almost reduced the relative risk of incident type 2 diabetes by 30 per cent and incident CVD by 20 per cent [45]. The observed similarities in total LTPA among our study participants could further strengthen that a healthy lifestyle in young adult offspring of type 1 diabetes mothers may have suppressed any clinical CVD differences.

This study has several strengths. To the best of our knowledge, this is the first study conducted to assess whether early subclinical CVD, measured as PWV, can be found in young adult offspring of mothers with type 1 diabetes. Furthermore, we have made a thorough evaluation of traditional CVD risk factors in every study participant. Also, this study population is unique and homogeneous, as the participants consist of same aged, normotensive, normoglycemic, and normal weight participants, thus minimizing other confounding factors on PWV. In addition to cfPWV measurements, we added crPWV and PWV ratio in our analysis, for comprehensive assessment of arterial stiffening.

Some limitations also need to be taken into account when considering our study results. First of all, the cross-sectional study design prevents further comments on causality. All study participants were with Finnish background, which limits the generalization of the results.

The overall participation rate was low, i.e., only 36% of the invited case participants attended. This might have affected the observed differences between the study groups, excluding people with more health problems, and consequently, leading to overrepresentation of healthy participants. Thus, the possibility of selection bias cannot be fully excluded. The role of epigenetics in the DOHaD hypothesis seems feasible, however, we could not assess its potential role in our study population. Lastly, we did not assess other subclinical CVD risk tools, such as carotid intima-media thickness, which could provide additional information on subclinical vascular changes.

We report a novel finding of increased arterial stiffness in young adult offspring of mothers with type 1 diabetes compared to offspring of mothers without diabetes. We could not observe any differences in traditional CVD risk factors between cases and controls, thus suggesting that arterial stiffening might be one of the early subclinical CVD changes to occur. However, since previous studies suggest that offspring of mothers with type 1 diabetes are more prone to a unfavorable metabolic profile than offspring of mothers without diabetes, from a preventive perspective it is of vital importance to encourage these individuals to maintain a sustainable and healthy lifestyle, reducing the cumulative exposure of CVD risk factors on the vascular wall, which would further increase arterial stiffening and the burden of CVD. Follow-up studies are warranted.

Availability of data and materials

The datasets generated and/or analysed during the current study are not publicly available due to legal reasons.

Abbreviations

cfPWV:

Carotid-femoral pulse wave velocity

crPWV:

Carotid-radial pulse wave velocity

DOHaD:

Developmental Origin of Health and Disease

LTPA:

Leisure-time physical activity

MET:

Metabolic equivalent of task

PWV:

Pulse wave velocity

References

  1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, Elkind MSV, Evenson KR, Ferguson JF, Gupta DK, Khan SS, Kissela BM, Knutson KL, Lee CD, Lewis TT, Liu J, Loop MS, Lutsey PL, Ma J, Mackey J, Martin SS, Matchar DB, Mussolino ME, Navaneethan SD, Perak AM, Roth GA, Samad Z, Satou GM, Schroeder EB, Shah SH, Shay CM, Stokes A, VanWagner LB, Wang NY, Tsao CW, American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254–743. https://doi.org/10.1161/CIR.0000000000000950.

    Article  PubMed  Google Scholar 

  2. United Nations. Sustainable Development Goals. https://sdgs.un.org/goals/goal3. Accessed 26 Apr 2022

  3. McGill HC Jr, McMahan CA, Herderick EE, Malcom GT, Tracy RE, Strong JP. Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr. 2000;72(5 Suppl):1307S-1315S. https://doi.org/10.1093/ajcn/72.5.1307s.

    Article  CAS  PubMed  Google Scholar 

  4. Arima Y, Fukuoka H. Developmental origins of health and disease theory in cardiology. J Cardiol. 2020;76(1):14–7. https://doi.org/10.1016/j.jjcc.2020.02.

    Article  PubMed  Google Scholar 

  5. Mitanchez D, Yzydorczyk C, Siddeek B, Boubred F, Benahmed M, Simeoni U. The offspring of the diabetic mother—short- and long-term implications. Best Pract Res Clin Obstet Gynaecol. 2015;29(2):256–69. https://doi.org/10.1016/j.bpobgyn.2014.08.004.

    Article  CAS  PubMed  Google Scholar 

  6. Yu Y, Arah OA, Liew Z, Cnattingius S, Olsen J, Sørensen HT, et al. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. BMJ. 2019;367:l6398. https://doi.org/10.1136/bmj.l6398.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Weiss PA, Scholz HS, Haas J, Tamussino KF, Seissler J, Borkenstein MH. Long-term follow-up of infants of mothers with type 1 diabetes: evidence for hereditary and nonhereditary transmission of diabetes and precursors. Diabetes Care. 2000;23(7):905–11. https://doi.org/10.2337/diacare.23.7.905.

    Article  CAS  PubMed  Google Scholar 

  8. Chirinos JA, Segers P, Hughes T, Townsend R. Large-artery stiffness in health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(9):1237–63. https://doi.org/10.1016/j.jacc.2019.07.012.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yu S, McEniery CM. Central versus peripheral artery stiffening and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2020;40(5):1028–33. https://doi.org/10.1161/ATVBAHA.120.313128.

    Article  CAS  PubMed  Google Scholar 

  10. Kucharska-Newton AM, Stoner L, Meyer ML. Determinants of vascular age: an epidemiological perspective. Clin Chem. 2019;65(1):108–18. https://doi.org/10.1373/clinchem.2018.287623.

    Article  CAS  PubMed  Google Scholar 

  11. Angoff R, Mosarla RC, Tsao CW. Aortic stiffness: epidemiology, risk factors, and relevant biomarkers. Front Cardiovasc Med. 2021;8: 709396. https://doi.org/10.3389/fcvm.2021.709396.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Vatner SF, Zhang J, Vyzas C, Mishra K, Graham RM, Vatner DE. Vascular stiffness in aging and disease. Front Physiol. 2021;12: 762437. https://doi.org/10.3389/fphys.2021.762437.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Milan A, Zocaro G, Leone D, et al. Current assessment of pulse wave velocity: comprehensive review of validation studies. J Hypertens. 2019;37(8):1547–57. https://doi.org/10.1097/HJH.0000000000002081.

    Article  CAS  PubMed  Google Scholar 

  14. Townsend RR, Wilkinson IB, Schiffrin EL, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66(3):698–722. https://doi.org/10.1161/HYP.0000000000000033.

    Article  CAS  PubMed  Google Scholar 

  15. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N, Stehouwer CD. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension. 2004;43(2):176–81. https://doi.org/10.1161/01.HYP.0000111829.46090.92.

    Article  CAS  PubMed  Google Scholar 

  16. Ben-Shlomo Y, Spears M, Boustred C, May M, Anderson SG, Benjamin EJ, Boutouyrie P, Cameron J, Chen CH, Cruickshank JK, Hwang SJ, Lakatta EG, Laurent S, Maldonado J, Mitchell GF, Najjar SS, Newman AB, Ohishi M, Pannier B, Pereira T, Vasan RS, Shokawa T, Sutton-Tyrell K, Verbeke F, Wang KL, Webb DJ, Willum Hansen T, Zoungas S, McEniery CM, Cockcroft JR, Wilkinson IB. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636–46. https://doi.org/10.1016/j.jacc.2013.09.063.

    Article  PubMed  Google Scholar 

  17. Ryder JR, Northrop E, Rudser KD, Kelly AS, Gao Z, Khoury PR, Kimball TR, Dolan LM, Urbina EM. Accelerated early vascular aging among adolescents with obesity and/or type 2 diabetes mellitus. J Am Heart Assoc. 2020;9(10):e014891. https://doi.org/10.1161/JAHA.119.014891.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. https://doi.org/10.1007/BF00280883.

    Article  CAS  PubMed  Google Scholar 

  19. Lakka TA, Salonen JT. Intra-person variability of various physical activity assessments in the Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Epidemiol. 1992;21(3):467–72.

    Article  CAS  Google Scholar 

  20. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–81.

    Article  Google Scholar 

  21. Higa R, Leonardi ML, Jawerbaum A. Intrauterine programming of cardiovascular diseases in maternal diabetes. Front Physiol. 2021;3(12): 760251. https://doi.org/10.3389/fphys.2021.760251.

    Article  Google Scholar 

  22. Murray R, Kitaba N, Antoun E, Titcombe P, Barton S, Cooper C, Inskip HM, Burdge GC, Mahon PA, Deanfield J, Halcox JP, Ellins EA, Bryant J, Peebles C, Lillycrop K, Godfrey KM, Hanson MA, EpiGen Consortium. Influence of Maternal lifestyle and diet on perinatal DNA methylation signatures associated with childhood arterial stiffness at 8 to 9 years. Hypertension. 2021;78(3):787–800. https://doi.org/10.1161/HYPERTENSIONAHA.121.17396.

    Article  CAS  PubMed  Google Scholar 

  23. Ullmo S, Vial Y, Di Bernardo S, Roth-Kleiner M, Mivelaz Y, Sekarski N, Ruiz J, Meijboom EJ. Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J. 2007;28(11):1319–25. https://doi.org/10.1093/eurheartj/ehl416.

    Article  CAS  PubMed  Google Scholar 

  24. Piepoli MF, Abreu A, Albus C, Ambrosetti M, Brotons C, Catapano AL, Corra U, Cosyns B, Deaton C, Graham I, Hoes A, Lochen ML, Matrone B, Redon J, Sattar N, Smulders Y, Tiberi M. Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2020;27(2):181–205. https://doi.org/10.1177/2047487319893035.

    Article  PubMed  Google Scholar 

  25. Reference Values for Arterial Stiffness Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values.’ Eur Heart J. 2010;31(19):2338–50. https://doi.org/10.1093/eurheartj/ehq165.

    Article  Google Scholar 

  26. Van Bortel LM, Laurent S, Boutouyrie P, Chowienczyk P, Cruickshank JK, De Backer T, Filipovsky J, Huybrechts S, Mattace-Raso FU, Protogerou AD, Schillaci G, Segers P, Vermeersch S, Weber T, Artery Society, European Society of Hypertension Working Group on Vascular Structure and Function, European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens. 2012;30(3):445–8. https://doi.org/10.1097/HJH.0b013e32834fa8b0.

    Article  CAS  PubMed  Google Scholar 

  27. Yuan WL, Lin J, Kramer MS, Godfrey KM, Gluckman PD, Chong YS, Shek LP, Tan KH, Chan SY, Eriksson JG, Yap F, Lee YS, Choo JTL, Ling LH. Maternal glycemia during pregnancy and child carotid intima media thickness, pulse wave velocity, and augmentation index. J Clin Endocrinol Metab. 2020;105(7):dgaa211. https://doi.org/10.1210/clinem/dgaa211.

    Article  PubMed  Google Scholar 

  28. Pettersson-Pablo P, Cao Y, Bäckström T, Nilsson TK, Hurtig-Wennlöf A. Body fat percentage and CRP correlates with a composite score of vascular risk markers in healthy, young adults - The Lifestyle, Biomarkers, and Atherosclerosis (LBA) study. BMC Cardiovasc Disord. 2020;20(1):77. https://doi.org/10.1186/s12872-020-01376-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Muhammad IF, Borné Y, Östling G, Kennbäck C, Gottsäter M, Persson M, Nilsson PM, Engström G. Arterial stiffness and incidence of diabetes: a population-based cohort study. Diabetes Care. 2017;40(12):1739–45. https://doi.org/10.2337/dc17-1071.

    Article  CAS  PubMed  Google Scholar 

  30. Zheng X, Jin C, Liu Y, Zhang J, Zhu Y, Kan S, Wu Y, Ruan C, Lin L, Yang X, Zhao X, Wu S. Arterial stiffness as a predictor of clinical hypertension. J Clin Hypertens (Greenwich). 2015;17(8):582–91. https://doi.org/10.1111/jch.12556.

    Article  Google Scholar 

  31. Vlachová Z, Bytoft B, Knorr S, Clausen TD, Jensen RB, Mathiesen ER, Højlund K, Ovesen P, Beck-Nielsen H, Gravholt CH, Damm P, Jensen DM. Increased metabolic risk in adolescent offspring of mothers with type 1 diabetes: the EPICOM study. Diabetologia. 2015;58(7):1454–63. https://doi.org/10.1007/s00125-015-3589-5.

    Article  CAS  PubMed  Google Scholar 

  32. Pitchika A, Jolink M, Winkler C, Hummel S, Hummel N, Krumsiek J, Kastenmüller G, Raab J, Kordonouri O, Ziegler AG, Beyerlein A. Associations of maternal type 1 diabetes with childhood adiposity and metabolic health in the offspring: a prospective cohort study. Diabetologia. 2018;61(11):2319–32. https://doi.org/10.1007/s00125-018-4688-x.

    Article  CAS  PubMed  Google Scholar 

  33. Lindsay RS, Nelson SM, Walker JD, Greene SA, Milne G, Sattar N, Pearson DW. Programming of adiposity in offspring of mothers with type 1 diabetes at age 7 years. Diabetes Care. 2010;33(5):1080–5. https://doi.org/10.2337/dc09-1766.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Pool LR, Aguayo L, Brzezinski M, Perak AM, Davis MM, Greenland P, Hou L, Marino BS, Van Horn L, Wakschlag L, Labarthe D, Lloyd-Jones D, Allen NB. Childhood risk factors and adulthood cardiovascular disease: a systematic review. J Pediatr. 2021;232:118-126.e23. https://doi.org/10.1016/j.jpeds.2021.01.053.

    Article  PubMed  Google Scholar 

  35. Aatola H, Hutri-Kähönen N, Juonala M, Viikari JS, Hulkkonen J, Laitinen T, Taittonen L, Lehtimäki T, Raitakari OT, Kähönen M. Lifetime risk factors and arterial pulse wave velocity in adulthood: the cardiovascular risk in young Finns study. Hypertension. 2010;55(3):806–11. https://doi.org/10.1161/HYPERTENSIONAHA.109.145102.

    Article  CAS  PubMed  Google Scholar 

  36. Muchira JM, Gona PN, Mogos MF, Stuart-Shor E, Leveille SG, Piano MR, Hayman LL. Parental cardiovascular health predicts time to onset of cardiovascular disease in offspring. Eur J Prev Cardiol. 2022;29(6):883–91. https://doi.org/10.1093/eurjpc/zwaa072.

    Article  PubMed  Google Scholar 

  37. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54(23):2129–38. https://doi.org/10.1016/j.jacc.2009.09.009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690–7. https://doi.org/10.1002/art.24092.

    Article  PubMed  Google Scholar 

  39. Fortier C, Agharazii M. Arterial Stiffness Gradient. Pulse (Basel). 2016;3(3–4):159–66. https://doi.org/10.1159/000438852.

    Article  PubMed  Google Scholar 

  40. Fortier C, Mac-Way F, Desmeules S, Marquis K, De Serres SA, Lebel M, Boutouyrie P, Agharazii M. Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension. 2015;65(2):378–84. https://doi.org/10.1161/HYPERTENSIONAHA.114.04587.

    Article  CAS  PubMed  Google Scholar 

  41. Niiranen TJ, Kalesan B, Larson MG, Hamburg NM, Benjamin EJ, Mitchell GF, Vasan RS. Aortic-Brachial arterial stiffness gradient and cardiovascular risk in the community: the Framingham heart study. Hypertension. 2017;69(6):1022–8. https://doi.org/10.1161/HYPERTENSIONAHA.116.08917.

    Article  CAS  PubMed  Google Scholar 

  42. Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT, Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219–29. https://doi.org/10.1016/S0140-6736(12)61031-9.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Germano-Soares AH, Andrade-Lima A, Menêses AL, Correia MA, Parmenter BJ, Tassitano RM, Cucato GG, Ritti-Dias RM. Association of time spent in physical activities and sedentary behaviors with carotid-femoral pulse wave velocity: a systematic review and meta-analysis. Atherosclerosis. 2018;269:211–8. https://doi.org/10.1016/j.atherosclerosis.2018.01.009.

    Article  CAS  PubMed  Google Scholar 

  44. Fernberg U, Fernström M, Hurtig-Wennlöf A. Higher total physical activity is associated with lower arterial stiffness in swedish, young adults: the cross-sectional lifestyle, biomarkers, and atherosclerosis study. Vasc Health Risk Manag. 2021;29(17):175–85. https://doi.org/10.2147/VHRM.S283211.

    Article  Google Scholar 

  45. Wahid A, Manek N, Nichols M, Kelly P, Foster C, Webster P, Kaur A, Friedemann Smith C, Wilkins E, Rayner M, Roberts N, Scarborough P. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5(9): e002495. https://doi.org/10.1161/JAHA.115.002495.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Open access funded by Helsinki University Library.

Funding

The Hospital District of Helsinki and Uusimaa, Finland, Finska Läkaresällskapet, Liv och Hälsa, Finnish Cultural Foundation, Biomedicum Helsinki Research Foundation, Juho Vainio Foundation, and Viipuri Tuberculosis Foundation awarded a research grant for this study. The funding sources had no role in planning or designing the study, nor in data collection, analyses or writing the article.

Author information

Authors and Affiliations

  1. Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

    Cedric A. Korpijaakko, Mia D. Eriksson, Niko S. Wasenius, Hannu Kautiainen, Johan G. Eriksson & Merja K. Laine

  2. Folkhälsan Research Center, Helsinki, Finland

    Cedric A. Korpijaakko, Mia D. Eriksson, Niko S. Wasenius, Hannu Kautiainen, Johan G. Eriksson & Merja K. Laine

  3. Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland

    Miira M. Klemetti & Kari Teramo

  4. Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland

    Miira M. Klemetti

  5. Primary Health Care Unit, Kuopio University Hospital, Kuopio, Finland

    Hannu Kautiainen

  6. Yong Loo Lin School of Medicine, Human Potential Translational Research Programme and Department of Obstetrics and Gynecology, National University Singapore, Singapore, Singapore

    Johan G. Eriksson

  7. Agency for Science, Technology and Research (A*STAR), Singapore Institute for Clinical Sciences (SICS), Singapore, Singapore

    Johan G. Eriksson

Authors
  1. Cedric A. Korpijaakko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mia D. Eriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Niko S. Wasenius
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miira M. Klemetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kari Teramo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hannu Kautiainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Johan G. Eriksson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Merja K. Laine
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Substantial contributions to conception and design: CK, HK, JGE, MKL; Acquisition of data: MKL, MMK; Data analysis: CK, MDE, HK, JGE, MKL; Interpretation of data: CK, MDE, HK, NW, KT, MMK, JGE, MKL; Drafting the article or revising it critically for important intellectual content: CK, MDE, HK, NW, KT, MMK, JGE, MKL; Final approval of the version to be published: CK, MDE, HK, NW, KT, MMK, JGE, MKL. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Cedric A. Korpijaakko.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the Ethics Committee of the Hospital District of Helsinki and Uusimaa (HUS/898/2017, 14 December 2017) and was conducted according to the ethical principles of the Helsinki Declaration. Prior to any clinical procedure written consent was provided by all study participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Korpijaakko, C.A., Eriksson, M.D., Wasenius, N.S. et al. Higher pulse wave velocity in young adult offspring of mothers with type 1 diabetes: a case–control study. Cardiovasc Diabetol 21, 178 (2022). https://doi.org/10.1186/s12933-022-01612-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12933-022-01612-7

Keywords

  • Cardiovascular disease
  • Offspring
  • Pregnancy
  • Pulse Wave Velocity
  • Type 1 diabetes

Cardiovascular Diabetology

ISSN: 1475-2840